Enoxacin
- Generic Name
- Enoxacin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H17FN4O3
- CAS Number
- 74011-58-8
- Unique Ingredient Identifier
- 325OGW249P
- Background
A broad-spectrum 6-fluoronaphthyridinone antibacterial agent (fluoroquinolones) structurally related to nalidixic acid.
- Indication
For the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: (1) uncomplicated urethral or cervical gonorrhea due to Neisseria gonorrhoeae, (2) uncomplicated urinary tract infections (cystitis) due to Escherichia coli, Staphylococcus epidermidis, or Staphylococcus saprophyticus, ...
- Associated Conditions
- -
- Associated Therapies
- -
Enoxacin for Amyotrophic Lateral Sclerosis (ALS)
- First Posted Date
- 2021-04-12
- Last Posted Date
- 2024-01-26
- Lead Sponsor
- McGill University
- Target Recruit Count
- 8
- Registration Number
- NCT04840823
- Locations
- 🇨🇦
Montreal Neurological Institute-Hospital, Montreal, Quebec, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath